Skip to content

High-intensity Exercise After Treatment

Enhancing Cognitive and Cardiovascular Function in Breast Cancer Survivors Through High-intensity Interval Training

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04950010
Acronym
HEAT
Enrollment
7
Registered
2021-07-02
Start date
2022-03-28
Completion date
2022-07-15
Last updated
2024-09-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Breast Neoplasm Female

Keywords

breast cancer, physical activity, cognitive function, exercise, cardiovascular function

Brief summary

This pilot study tests the feasibility and preliminary efficacy of an 8-week, 3-arm pilot exercise trial in which 45 breast cancer survivors will be randomized to high-intensity interval training (HIIT; n=15), moderate-intensity aerobic training (MOD; n=15), or Usual Care (UC; n=15).

Detailed description

Aim 1: Determine the feasibility and acceptability of an 8-week high-intensity interval training (HIIT) program compared with a standard moderate-intensity aerobic training (MOD) program in 45 breast cancer survivors prescribed aromatase inhibitors. Aim 2: Calculate effect sizes associated with the 8-week HIIT program, compared with MOD and Usual Care (UC), on cognitive and cardiovascular functions in 45 breast cancer survivors. Eligible individuals will be women diagnosed with Stages I-IIIa breast cancer, have completed primary treatment (i.e., surgery, chemotherapy, and/or radiation therapy), and currently prescribed an aromatase inhibitor. The specific aims are: 1) Determine the feasibility and acceptability of an 8-week high-intensity interval training (HIIT) program compared with a standard moderate-intensity (MOD) program; and 2) Calculate effect sizes associated with the 8-week HIIT program, compared with MOD and usual care (UC), on cognitive and cardiovascular functions. Cognitive function is operationalized as performance on executive function and working memory tasks. Cardiovascular function is operationalized as exercise capacity (VO2peak, heart rate recovery), resting function (heart rate, blood pressure), and cardiovascular structure/function (arterial stiffness, arterial wall thickness, endothelial function). Associations between change in cardiovascular outcomes and change in cognitive outcomes across the intervention period will also be explored.

Interventions

BEHAVIORALHigh-Intensity Interval Training

HIIT is a type of training in which short periods of high-intensity anaerobic exercise (1-4 minutes at 80-95% of VO2peak) are alternated with less intense aerobic recovery periods (1-3 minutes at 50-60% VO2peak). Individually-tailored exercise prescriptions will be developed based upon each participant's baseline maximal graded exercise test (heart rate corresponding with %VO2 peak) and symptom limitation. Sessions will be progressive in nature such that the volume of exercise (i.e., number and intensity of intervals) increases across weeks. Intervals will progress from a heart rate corresponding with 75% VO2peak in Week 1 to 90-95% VO2peak in Weeks 5-8. Sessions will be \ 30 minutes in length. Indoor cycling is the primary mode of exercise.

Individually-tailored exercise prescriptions will be developed based upon each participant's baseline maximal graded exercise test (heart rate corresponding with %VO2 peak) and symptom limitation. Sessions will be progressive in nature such that the volume of exercise increases across weeks. Indoor cycling is the primary mode of exercise. Sessions will include moderate-intensity cycling that progresses from a heart rate corresponding with 55-60% VO2peak for 30 minutes in Week 1 to 65-70% VO2peak for 45-50 minutes in Weeks 5-8.

Sponsors

National Institute of General Medical Sciences (NIGMS)
CollaboratorNIH
University of Nebraska
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult female (aged 19 or older) * First, primary diagnosis of Stage I-IIIa breast cancer * Hormone receptor positive (ER+ and/or PR+) diagnosis * Human epidermal growth factor receptor 2 negative (HER2-) diagnosis * Completed primary adjuvant treatment (i.e., surgery, chemotherapy, and/or radiation therapy) * Currently prescribed an aromatase inhibitor * No evidence of possible cognitive impairment as assessed using the Telephone Interview of Cognitive Status (TICS-M; score \>21) * Sedentary except for casual lifestyle recreation. This is defined as self-reporting 20+ minutes of exercise physical activity on 2 or fewer days per week within the previous six months. * Receive physician's clearance to participate in an exercise program * Agree to be randomized * Fully vaccinated for COVID-19 ≥2 weeks prior to participation * Provide written informed consent to participate in study

Exclusion criteria

* Males. * Stage 0 breast cancer diagnosis or metastatic disease * Currently receiving chemotherapy or radiation therapy for any cancer * Scheduled to receive breast surgery (e.g., mastectomy, reconstructive surgery) during the study period * Second cancer diagnosis (excluding non-invasive skin cancers; including breast cancer recurrence) * Self-report an 20+ minutes of exercise physical activity on 3+ days per week for the previous 6 months * Pregnant or plan to become pregnant during study period. * Is not cleared to participate in exercise by a physician. * Enrolled in another physical activity program * Unable to cycle on a stationary bike * Unwilling to complete study requirements * History of stroke, transient ischemic attack, other neurological disorders, or brain surgery involving tissue removal * Clinically significant TICS-M score (\<21) during baseline procedures * Not fully vaccinated for COVID-19

Design outcomes

Primary

MeasureTime frameDescription
Change in spatial working memory reaction timeBaseline, post-intervention (Week 9)Change in reaction time on spatial working memory task, with faster reaction times indicating better spatial working memory
Acceptability of the exercise programspost-interventionsatisfaction with the exercise program as measured by a satisfaction survey. Survey uses a 5-point Likert-type scale. Satisfaction for each item is defined as reporting 4-5 on the scale (i.e., somewhat agree or completely agree).
Change in executive function processingBaseline, post-intervention (Week 9)Change in completion time on Trails B task, with higher values indicating lower executive function.
Change in cognitive flexibilityBaseline, post-intervention (Week 9)Change in reaction time on Task-switch task, with higher values indicating lower cognitive flexibility
Participation RateBaselineSample size / \[1-(#ineligible/# exposed to recruitment)\*(#exposed to recruitment)\]
Adherence to the exercise programspost-intervention (Week 9)average number of exercise sessions (out of 24) attended
Compliance of the exercise programspost-interventionaverage number of exercise sessions (out of 24) in which the prescribed exercise duration and intensity are achieved

Secondary

MeasureTime frameDescription
Carotid arterial wall thicknessBaseline, post-intervention (Week 9)will be estimated from vascular ultrasound and expressed as average and maximum mm
Endothelial functionBaseline, post-intervention (Week 9)estimated from brachial artery flow mediated dilation and expressed as percent change in brachial artery diameter relative to baseline diameter
Change in Cardiorespiratory FitnessBaseline, post-intervention (Week 9)Change in Peak VO2 as measured by a modified Balke treadmill graded exercise test protocol.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026